Insulin treatment and longer diabetes duration both predict poorer glycaemic response to liraglutide treatment in type 2 diabetes: the Association of British Clinical Diabetologists Nationwide Liraglutide Audit

User

All issues

2014-present
Browse

View listing of all 2001-2013 issues here.
Click on the issue you want to view it at http://dvd.sagepub.com

About The Authors

Ken Y Thong
School of Medicine and Pharmacology, University of Western Australia, Perth, Australia

Barbara M Mcgowan
Guy's and St Thomas' NHS Trust, London, UK

Thein Htay
Queen Elizabeth II, Welwyn Garden City, UK

Andrew Pernet
King’s College Hospital, London, UK

Chris Kelly
Stirling Community Hospital, UK

Chinnadorai Rajeswaran
Mid Yorkshire NHS Trust, UK

Jill Howell
Pontefract General Infirmary, Yorkshire, UK

Catriona Duncan
Kirkcaldy Acute Hospitals NHS Trust, UK

Berit Inkster
Royal Infirmary of Edinburgh, UK

Linda Buchanan
Forth Valley Royal Hospital, Larbert, UK

Saiful Kassim
Causeway Hospital, Northern Ireland, UK

Rahul Nayer
City Hospitals Sunderland, UK

Nicholas D Barwell
Forth Valley Royal Hospital, Larbert, UK

Christopher Walton
Hull Royal Infirmary, Hull, UK

Robert EJ Ryder
Sandwell & West Birmingham NHS Trust, Birmingham, UK

ABCD Nationwide Liraglutide Audit contributors
Appendix 1 (see online version of article at www.bjdvd.com)

Hosted By

The Journal of the Association of British Clinical Diabetologists